A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

The CDC Recommends a New COVID-19 Vaccine Series


The United States Centers for Disease Control and Prevention released a statement on July 20 recommending the addition of the Novavax COVID-19 vaccine series to the current armamentarium of immunizations against SARS-CoV-2 among individuals ages 18 and older. The Novavax currently has Emergency Use Authorization from the US Food and Drug Administration. The vaccine was funded by the US Department of Defense and uses spike proteins and an immune-system stimulator to create an immune response to the novel coronavirus in recipients. A clinical trial of more than 29,000 subjects revealed the Novavax vaccine is both safe and effective. It is a two-dose vaccine with injections spaced 3 to 4 weeks apart. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy